Neoplastic cells express immunoinhibitory molecules (immune checkpoints), such as programmed death ligand-1 (PD-L1), programmed death ligand-2 (PD-L2), and human leukocyte antigen-G (HLA-G) that make them more resistant to attacks by specific tumor T cells. Here, PDCD1LG2 is linked to neoplasm.